No fees unless we win.
Get a free consultation
A new study published in JAMA Internal Medicine indicates that children and young adults who start taking antidepressants in high doses are more likely to think about or attempt to commit suicide.
According to the study and Fox News, researchers found that young people between ages 10 and 24 who started antidepressant therapy at high doses were twice as likely to attempt or think about suicide over the first 90 days of treatment, compared to those who started taking the drugs at the doses recommended by doctors’ guidelines.
The researchers pointed out that this translates into about one additional event of suicidal behavior for those who take high doses of antidepressants. “There is no evidence that starting at a higher dose is beneficial,” stated Dr. David Brent of the University of Pittsburgh, who wrote a commentary about the study.
Fox News reported that suicide is the third leading cause of death among young people between the ages of 10 and 24. The news outlet also reported that each year about 157,000 young people between ages 10 and 24 receive medical care for injuries resulting from suicidal behavior at emergency rooms across the country.
The researchers reportedly used data gathered from 1998 through 2010 on people with depression, ages 10 to 64.
If you are worried about your antidepressant prescription dosage, you should contact your doctor or healthcare provider. SSRIs including Prozac, Zoloft, Paxil, Lexapro, Luvox and Celexa are very powerful drugs. In addition to suicidal thoughts, they have been linked to birth defects among pregnant women taking them, including cleft lip and palate, craniosynostosis, limb defects, clubfoot and anal atresia.
Talk with our SSRI lawyers by calling toll- free at (888)841-9623 if you have suffered because you took one of these powerful drugs.
ZK’s ‘Did You Know?’: SSRIs are often prescribed for the treatment of depression, anxiety disorders and personality disorders.
Source: http://www.foxnews.com/health/2014/04/29/high-doses-antidepressants-linked-to-suicide-behavior-in-younger-patients/
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
